IGM Biosciences, Inc. (IGMS)

IGM Biosciences Statistics

Total Valuation

IGMS has a market cap or net worth of $410.30 million. The enterprise value is $237.37 million.

Market Cap	410.30M
Enterprise Value	237.37M

Important Dates

The last earnings date was Friday, November 8, 2024, before market open.

Earnings Date	Nov 8, 2024
Ex-Dividend Date	n/a

Share Statistics

IGMS has 59.46 million shares outstanding. The number of shares has increased by 24.54% in one year.

Current Share Class	34.08M
Shares Outstanding	59.46M
Shares Change (YoY)	+24.54%
Shares Change (QoQ)	+0.37%
Owned by Insiders (%)	2.49%
Owned by Institutions (%)	18.75%
Float	11.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	142.54
Forward PS	38.84
PB Ratio	5.20
P/TBV Ratio	5.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	81.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.58.

Current Ratio	5.22
Quick Ratio	5.00
Debt / Equity	0.58
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -132.11% and return on invested capital (ROIC) is -69.34%.

Return on Equity (ROE)	-132.11%
Return on Assets (ROA)	-37.38%
Return on Capital (ROIC)	-69.34%
Revenue Per Employee	$13,027
Profits Per Employee	-$981,442
Employee Count	224
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

In the past 12 months, IGMS has paid $242,000 in taxes.

Income Tax	242,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -11.31% in the last 52 weeks. The beta is 0.01, so IGMS's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	-11.31%
50-Day Moving Average	12.15
200-Day Moving Average	10.57
Relative Strength Index (RSI)	29.48
Average Volume (20 Days)	219,462

Short Selling Information

The latest short interest is 2.70 million, so 4.55% of the outstanding shares have been sold short.

Short Interest	2.70M
Short Previous Month	2.84M
Short % of Shares Out	4.55%
Short % of Float	23.11%
Short Ratio (days to cover)	11.22

Income Statement

In the last 12 months, IGMS had revenue of $2.92 million and -$219.84 million in losses. Loss per share was -$3.65.

Revenue	2.92M
Gross Profit	-181.46M
Operating Income	-232.89M
Pretax Income	-236.33M
Net Income	-219.84M
EBITDA	-223.95M
EBIT	-232.89M
Loss Per Share	-$3.65

Balance Sheet

The company has $218.79 million in cash and $45.86 million in debt, giving a net cash position of $172.93 million or $2.91 per share.

Cash & Cash Equivalents	218.79M
Total Debt	45.86M
Net Cash	172.93M
Net Cash Per Share	$2.91
Equity (Book Value)	78.95M
Book Value Per Share	1.33
Working Capital	185.67M

Cash Flow

In the last 12 months, operating cash flow was -$166.18 million and capital expenditures -$6.44 million, giving a free cash flow of -$172.62 million.

Operating Cash Flow	-166.18M
Capital Expenditures	-6.44M
Free Cash Flow	-172.62M
FCF Per Share	-$2.90

Margins

Gross Margin	n/a
Operating Margin	-7,981.25%
Pretax Margin	-7,525.74%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

IGMS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.54%
Shareholder Yield	-24.54%
Earnings Yield	-53.58%
FCF Yield	-42.07%

Analyst Forecast

The average price target for IGMS is $17.43, which is 152.61% higher than the current price. The consensus rating is "Buy".

Price Target	$17.43
Price Target Difference	152.61%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	104.79%
EPS Growth Forecast (5Y)	-28.93%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IGMS has an Altman Z-Score of -4.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.85
Piotroski F-Score	3